Skip to main content
SpringerLink
Log in

Myeloperoxidase G463A polymorphism and risk of lung cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Myeloperoxidase (MPO) is a phase I enzyme playing a crucial role in metabolically activating a wide range of procarcinogens, such as polycyclic aromatic hydrocarbons and aromatic amines. The G463A polymorphism in the promoter region of the MPO gene has been indicated in lung cancer risk. To investigate the precise association of MPO G463A polymorphism with the lung cancer risk, we performed this comprehensive meta-analysis with large available data published to date. The included 24 individual studies involving a total of 8,313 cases and 8,728 controls were identified by searching the PubMed, Embase, and Wanfang databases. The crude odds ratios (ORs) and the corresponding 95 % confidence intervals (CIs) were calculated to estimate the association. Stratified analyses by ethnicity, source of controls, smoking status, and histological types were also conducted. Overall, the MPO G463A polymorphism was negatively related to the development of lung cancer in the following genetic models (A vs. G, OR = 0.90, 95 % CI = 0.82–0.99, P OR = 0.029; GA vs. GG, OR = 0.89, 95 % CI = 0.80–0.98, P OR = 0.022; AA + GA vs. GG, OR = 0.89, 95 % CI = 0.81–0.98, P OR = 0.023). Stratified analyses by ethnicity indicated that the variant genotype of MPO G463A was associated with a decreased risk of lung cancer in Asians and Caucasians. Similar findings were observed among the smokers and population-based case–control studies. The MPO G463A polymorphism seemed to exert no effect on lung adenocarcinoma and squamous cell carcinoma. The comprehensive meta-analysis shows that the polymorphism of MPO G463A is a protective factor for lung cancer, particularly among the populations of Asians, Caucasians, and smokers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Steliga MA, Dresler CM. Epidemiology of lung cancer: smoking, secondhand smoke, and genetics. Surg Oncol Clin N Am. 2011;20:605–18.

    Article  PubMed  Google Scholar 

  3. Ginsberg MS. Epidemiology of lung cancer. Semin Roentgenol. 2005;40:83–9.

    Article  PubMed  Google Scholar 

  4. Ahn MJ, Park SY, Kim WK, Cho JH, Chang BJ, Kim DJ, et al. A single nucleotide polymorphism in the phospholipase D1 gene is associated with risk of non-small cell lung cancer. Int J Biomed Sci. 2012;8:121–8.

    CAS  PubMed  Google Scholar 

  5. Kanzaki H, Ouchida M, Hanafusa H, Yamamoto H, Suzuki H, Yano M, et al. The association between RAD18 Arg302Gln polymorphism and the risk of human non-small-cell lung cancer. J Cancer Res Clin Oncol. 2008;134:211–7.

    Article  CAS  PubMed  Google Scholar 

  6. Zheng J, Jiang L, Zhang L, Yang L, Deng J, You Y, et al. Functional genetic variations in the IL-23 receptor gene are associated with risk of breast, lung and nasopharyngeal cancer in Chinese populations. Carcinogenesis. 2012;33:2409–16.

    Article  CAS  PubMed  Google Scholar 

  7. Klebanoff SJ. Myeloperoxidase. Proc Assoc Am Physicians. 1999;111:383–9.

    CAS  PubMed  Google Scholar 

  8. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol. 2005;77:598–625.

    Article  CAS  PubMed  Google Scholar 

  9. Anand U, Anand CV. Myeloperoxidase: a new twist to an old tale. Indian J Clin Biochem. 2012;27:107–9.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Wheatley-Price P, Asomaning K, Reid A, Zhai R, Su L, Zhou W, et al. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer. 2008;112:1037–42.

    Article  CAS  PubMed  Google Scholar 

  11. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, et al. Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res. 2004;64:7634–9.

    Article  CAS  PubMed  Google Scholar 

  12. Pabalan N, Jarjanazi H, Sung L, Li H, Ozcelik H. Menopausal status modifies breast cancer risk associated with the myeloperoxidase (MPO) G463A polymorphism in Caucasian women: a meta-analysis. PLoS One. 2012;7:e32389.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Li D, Diao Y, Li H, Fang X. Association of the polymorphisms of MTHFR C677T, VDR C352T, and MPO G463A with risk for esophageal squamous cell dysplasia and carcinoma. Arch Med Res. 2008;39:594–600.

    Article  CAS  PubMed  Google Scholar 

  14. Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256–66.

    CAS  PubMed  Google Scholar 

  15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed  Google Scholar 

  16. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  PubMed  Google Scholar 

  17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  CAS  PubMed  Google Scholar 

  19. Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 70–1.

    Article  CAS  PubMed  Google Scholar 

  20. London SJ, Lehman TA, Taylor JA. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res. 1997;57:5001–3.

    CAS  PubMed  Google Scholar 

  21. Cascorbi I, Henning S, Brockmoller J, Gephart J, Meisel C, Muller JM, et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant—463A of the myeloperoxidase gene. Cancer Res. 2000;60:644–9.

    CAS  PubMed  Google Scholar 

  22. Le Marchand L, Seifried A, Lum A, Wilkens LR. Association of the myeloperoxidase -463G → a polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2000;9:181–4.

    PubMed  Google Scholar 

  23. Misra RR, Tangrea JA, Virtamo J, Ratnasinghe D, Andersen MR, Barrett M, et al. Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. Cancer Lett. 2001;164:161–7.

    Article  CAS  PubMed  Google Scholar 

  24. Lv WF, Qi J, Xing DY, Tan W, Miao XP, Su W, et al. Lung cancer risk associated with gene polymorphism in myeloperoxidase (−463 G/A) in a Chinese population. Chin J Oncol. 2002;24:250–3 [Article in Chinese].

    Google Scholar 

  25. Feyler A, Voho A, Bouchardy C, Kuokkanen K, Dayer P, Hirvonen A, et al. Point: myeloperoxidase -463G → a polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1550–4.

    CAS  PubMed  Google Scholar 

  26. Dally H, Gassner K, Jager B, Schmezer P, Spiegelhalder B, Edler L, et al. Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO −463 A allele is associated with reduced risk for small cell lung cancer in smokers. Int J Cancer. 2002;102:530–5.

    Article  CAS  PubMed  Google Scholar 

  27. Lu W, Xing D, Qi J, Tan W, Miao X, Lin D. Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population. Int J Cancer. 2002;102:275–9.

    Article  CAS  PubMed  Google Scholar 

  28. Schabath MB, Spitz MR, Delclos GL, Gunn GB, Whitehead LW, Wu X. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Ind Med. 2002;42:29–37.

    Article  CAS  PubMed  Google Scholar 

  29. Xu LL, Liu G, Miller DP, Zhou W, Lynch TJ, Wain JC, et al. Counterpoint: the myeloperoxidase -463G → a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol Biomarkers Prev. 2002;11:1555–9.

    CAS  PubMed  Google Scholar 

  30. Kantarci OH, Lesnick TG, Yang P, Meyer RL, Hebrink DD, McMurray CT, et al. Myeloperoxidase −463 (G → A) polymorphism associated with lower risk of lung cancer. Mayo Clin Proc. 2002;77:17–22.

    Article  CAS  PubMed  Google Scholar 

  31. Wu XM, Zhou YK, Ren S, Hao QL. Gene polymorphism of myeloperoxidase and genetic susceptibility to lung cancer. Chin J Cancer. 2003;22:912–5 [Article in Chinese].

    CAS  Google Scholar 

  32. Cajas-Salazar N, Sierra-Torres CH, Salama SA, Zwischenberger JB, Au WW. Combined effect of MPO, GSTM1 and GSTT1 polymorphisms on chromosome aberrations and lung cancer risk. Int J Hyg Environ Health. 2003;206:473–83.

    Article  CAS  PubMed  Google Scholar 

  33. Chevrier I, Stucker I, Houllier AM, Cenee S, Beaune P, Laurent-Puig P, et al. Myeloperoxidase: new polymorphisms and relation with lung cancer risk. Pharmacogenet. 2003;13:729–39.

    Article  CAS  Google Scholar 

  34. Liu G, Zhou W, Wang LI, Park S, Miller DP, Xu LL, et al. MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma. Cancer Lett. 2004;214:69–79.

    Article  CAS  PubMed  Google Scholar 

  35. Chan EC, Lam SY, Fu KH, Kwong YL. Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Genet Cytogenet. 2005;162:10–20.

    Article  CAS  PubMed  Google Scholar 

  36. Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis. 2006;27:525–32.

    Article  CAS  PubMed  Google Scholar 

  37. Park JH, Park JM, Kim EJ, Cha SI, Lee EB, Kim CH, et al. Myeloperoxidase -463G > A polymorphism and risk of primary lung cancer in a Korean population. Cancer Detect Prev. 2006;30:257–61.

    Article  CAS  PubMed  Google Scholar 

  38. Zhang TY, Hong XT, Wu YJ, Wu YM. Myeloperoxidase polymorphism in lung cancer patients of Henan Han population. J Zhengzhou Univ. 2007;42:448–50 [Article in Chinese].

    CAS  Google Scholar 

  39. Yang M, Choi Y, Hwangbo B, Lee JS. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer. 2007;57:135–42.

    Article  PubMed  Google Scholar 

  40. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB, et al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis. 2008;29:1164–9.

    Article  CAS  PubMed  Google Scholar 

  41. Yoon KA, Kim JH, Gil HJ, Hwang H, Hwangbo B, Lee JS. CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women. Lung Cancer. 2008;60:40–6.

    Article  PubMed  Google Scholar 

  42. Klinchid J, Chewaskulyoung B, Saeteng S, Lertprasertsuke N, Kasinrerk W, Cressey R. Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women. Cancer Genet Cytogenet. 2009;195:143–9.

    Article  CAS  PubMed  Google Scholar 

  43. Arslan S, Pinarbasi H, Silig Y. Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population. Mol Med Rep. 2011;4:87–92.

    CAS  PubMed  Google Scholar 

  44. Wang S, Zhu J, Zhang R, Gu Z. Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer. Tumour Biol. 2013;34:1045–52.

    Article  CAS  PubMed  Google Scholar 

  45. Shiels MS, Chaturvedi AK, Katki HA, Gochuico BR, Caporaso NE, Engels EA. Circulating markers of interstitial lung disease and subsequent risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:2262–72.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Yang JP, Wang WB, Yang XX, Yang L, Ren L, Zhou FX, et al. The MPO-463G > A polymorphism and lung cancer risk: a meta-analysis based on 22 case–control studies. PLoS One. 2013;8:e65778.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Zhong L, Goldberg MS, Parent ME, Hanley JA. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer. 2000;27:3–18.

    Article  CAS  PubMed  Google Scholar 

  48. Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med. 2005;7:463–78.

    Article  CAS  PubMed  Google Scholar 

  49. Vineis P, Hoek G, Krzyzanowski M, Vigna-Taglianti F, Veglia F, Airoldi L, et al. Lung cancers attributable to environmental tobacco smoke and air pollution in non-smokers in different European countries: a prospective study. Environ Health. 2007;6:7.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Boffetta P, Nyberg F. Contribution of environmental factors to cancer risk. Br Med Bull. 2003;68:71–94.

    Article  CAS  PubMed  Google Scholar 

  51. Li QD, Li H, Wang MS, Diao TY, Zhou ZY, Fang QX, et al. Multi-susceptibility genes associated with the risk of the development stages of esophageal squamous cell cancer in Feicheng County. BMC Gastroenterol. 2011;11:74.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  52. Koutros S, Andreotti G, Berndt SI, Hughes Barry K, Lubin JH, Hoppin JA, et al. Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer. Pharmacogenet Genomics. 2011;21:615–23.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. Yuzhalin AE, Kutikhin AG. Common genetic variants in the myeloperoxidase and paraoxonase genes and the related cancer risk: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2012;30:287–322.

    Article  CAS  PubMed  Google Scholar 

  54. Li Y, Ambrosone CB, McCullough MJ, Ahn J, Stevens VL, Thun MJ, et al. Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis. 2009;30:777–84.

    Article  CAS  PubMed  Google Scholar 

  55. Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB. Are female smokers at higher risk for lung cancer than male smokers? A case–control analysis by histologic type. Am J Epidemiol. 1993;138:281–93.

    CAS  PubMed  Google Scholar 

  56. Kreuzer M, Boffetta P, Whitley E, Ahrens W, Gaborieau V, Heinrich J, et al. Gender differences in lung cancer risk by smoking: a multicentre case–control study in Germany and Italy. Br J Cancer. 2000;82:227–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Dahabreh IJ, Trikalinos TA, Paulus JK. Parity and risk of lung cancer in women: systematic review and meta-analysis of epidemiological studies. Lung Cancer. 2012;76:150–8.

    Article  PubMed  Google Scholar 

  58. Schabath MB, Spitz MR, Zhang X, Delclos GL, Wu X. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis. 2000;21:1163–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Infectious Disease, Tangshan Worker’s Hospital, No. 27 Wenhua Road, Tangshan, Hebei, 063000, China

    Junrui Li & Baochun Zhao

  2. Department of Emergency Internal Medicine, Tangshan Worker’s Hospital, Tangshan, Hebei, 063000, China

    Yingju Fu

  3. Department of Oncology, Tangshan Worker’s Hospital, Tangshan, Hebei, 063000, China

    Ying Xiao

  4. Department of Neurology, Affiliated Hospital of Hebei United University, Tangshan, Hebei, 063000, China

    Ruiying Chen

Authors
  1. Junrui Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yingju Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Baochun Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ying Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ruiying Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Junrui Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, J., Fu, Y., Zhao, B. et al. Myeloperoxidase G463A polymorphism and risk of lung cancer. Tumor Biol. 35, 821–829 (2014). https://doi.org/10.1007/s13277-013-1113-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1113-4

Keywords

Search

Navigation